Twist Bioscience (TWST) Gains from Sales and Divestitures (2019 - 2021)
Twist Bioscience (TWST) has 3 years of Gains from Sales and Divestitures data on record, last reported at $62000.0 in Q4 2021.
- On a quarterly basis, Gains from Sales and Divestitures rose 14.81% to $62000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $62000.0, a 14.81% increase, with the full-year FY2021 number at $237000.0, up 33.15% from a year prior.
- Gains from Sales and Divestitures reached $62000.0 in Q4 2021 per TWST's latest filing, down from $237000.0 in the prior quarter.
- Over the last five years, Gains from Sales and Divestitures for TWST hit a ceiling of $237000.0 in Q3 2021 and a floor of $8000.0 in Q3 2019.
- A 3-year average of $80777.8 and a median of $57000.0 in 2021 define the central range for Gains from Sales and Divestitures.
- Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 2125.0% in 2020, then rose 14.81% in 2021.
- Tracing TWST's Gains from Sales and Divestitures over 3 years: stood at $8000.0 in 2019, then soared by 575.0% to $54000.0 in 2020, then grew by 14.81% to $62000.0 in 2021.
- Business Quant data shows Gains from Sales and Divestitures for TWST at $62000.0 in Q4 2021, $237000.0 in Q3 2021, and $57000.0 in Q2 2021.